𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.3.a.015 Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients

✍ Scribed by Y. Inoue; H. Suzuki; M. Ootomo; S. Takeda; Y. Kawaguchi; K. Gen

Book ID
118597295
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
42 KB
Volume
20
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of long-acting rispe
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder
✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; MariΓ«lle Eerd πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi

Long-term safety and efficacy of long-ac
Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients
✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (β‰₯65 years) with psychosis stabilized on oral or depot a